 |
|
|
|
 |
USAID Information:
External Links:
|
|
|
|
|
|
|
|
USAID Provides Reagents for TB Treatment Program
In January, the U.S. Centers for Disease Control and Prevention (CDC) and Project HOPE, implementers of USAID’s Tuberculosis (TB) prevention project, provided much-needed reagents for diagnostics laboratories at USAID’s TB Directly-Observed Treatment Short course (DOTS) pilot sites in Ashgabat, Turkmenbashi, Dushak, and Mary.
Successful implementation of TB-DOTS treatment requires an adequate level of laboratory diagnostic and treatment control. Unfortunately, at the end of 2005, Turkmenistan failed to ensure necessary quantities of laboratory reagents, which threatened the entire TB-DOTS program. Under these critical conditions, USAID stepped in to provide the Turkmen Government with reagents that will result in continuous provision of early diagnostics and treatment of new TB cases.
The TB incidence rate in Turkmenistan is considered high at 105 cases per 100,000 people. Since 1999, USAID’s TB prevention projects focused on four TB treatment pilots, where USAID provided equipment, medicines, and training for health professionals and laboratory staff. Due to the successes of the TB treatment at the USAID-supported pilots, the Government of Turkmenistan approved the National TB DOTS program in 2005, which will expand the treatment program countrywide.
 |
Successful TB treatment requires an adequate level of laboratory diagnostic and treatment control
PHOTO CREDIT: USAID Archives |
Back to Top ^ |
